A business in context

SLDB research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-02 · 0001193125-26-415649

  2. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-338438 · Items 8.01,9.01

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-337935

  4. 4 · Ownership change

    Report date 2026-07-02 · 0001193125-26-297456

  5. 4 · Ownership change

    Report date 2026-06-10 · 0001193125-26-267504

  6. 4 · Ownership change

    Report date 2026-06-10 · 0001193125-26-267503

  7. 4 · Ownership change

    Report date 2026-06-10 · 0001193125-26-267502

  8. 4 · Ownership change

    Report date 2026-06-10 · 0001193125-26-267501

  9. 4 · Ownership change

    Report date 2026-06-10 · 0001193125-26-267500

  10. 4 · Ownership change

    Report date 2026-06-10 · 0001193125-26-267499

  11. 8-K · Current report

    Report date 2026-06-10 · 0001193125-26-265804 · Items 5.07

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-219337

  13. DEF 14A · Proxy statement

    Report date 2026-06-10 · 0001193125-26-173642

  14. 8-K · Current report

    Report date 2026-04-10 · 0001193125-26-151259 · Items 5.02

  15. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-115928

  16. 8-K · Current report

    Report date 2026-03-11 · 0001193125-26-102489 · Items 7.01,8.01

  17. 8-K · Current report

    Report date 2026-03-06 · 0001193125-26-096709 · Items 1.01,2.02,3.02,8.01,9.01

  18. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-262818

  19. 8-K · Current report

    Report date 2025-11-03 · 0001193125-25-262795 · Items 2.02,7.01,8.01,9.01

  20. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-107279

  21. 8-K · Current report

    Report date 2025-06-12 · 0000950170-25-086215 · Items 5.02,5.07,9.01

  22. 8-K · Current report

    Report date 2025-05-15 · 0000950170-25-072792 · Items 8.01,9.01

  23. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-072560

  24. DEF 14A · Proxy statement

    Report date 2025-06-12 · 0001193125-25-096695

  25. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-034644

  26. 8-K · Current report

    Report date 2025-02-18 · 0001193125-25-028691 · Items 1.01,8.01,9.01

  27. 8-K · Current report

    Report date 2025-02-18 · 0001193125-25-028146 · Items 8.01

  28. 8-K · Current report

    Report date 2025-02-18 · 0001193125-25-028123 · Items 2.02,8.01,9.01

  29. SC 13G/A · Ownership disclosure

    0001193805-24-001357

  30. SC 13D/A · Ownership disclosure

    0001193125-24-259014

  31. SC 13G · Ownership disclosure

    0000902664-24-006562

  32. SC 13G/A · Ownership disclosure

    0001193125-24-256066

  33. SC 13G/A · Ownership disclosure

    0000902664-24-006394

  34. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-122247

  35. SC 13G/A · Ownership disclosure

    0001273087-24-000112

  36. 10-Q · Quarterly report

    Report date 2024-06-30 · 0000950170-24-096130

  37. SC 13G/A · Ownership disclosure

    0001193125-24-193051

  38. SC 13D/A · Ownership disclosure

    0001104659-24-070940

  39. SC 13D/A · Ownership disclosure

    0001193125-24-159367

  40. 8-K · Current report

    Report date 2024-06-07 · 0001193125-24-159143 · Items 5.02,5.07,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 2 transaction rows2MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

2 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-07-02
2026-07-07
SMITH IAN FM · Exercise / conversion
Acquired
Common Stock3440.0n/a
2026-07-02
2026-07-07
SMITH IAN FM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
3440.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001707502Solid Biosciences Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • Solid Biosciences, LLC · former SEC name · 2017-08-04 to 2018-01-25

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2022-12-31$8.09M$9.32M
2021-12-31$13.62M$16.93M
2020-12-31$0$0
2019-12-31$0$0
2018-12-31$0$0
2017-12-31$0$0

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗